Myomo, Inc. – AMEX:MYO
Myomo stock price today
$1.15
-5.22
-81.95%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 11 hours
Myomo stock price monthly change
+38.78%
month
Myomo stock price quarterly change
+38.78%
quarter
Myomo stock price yearly change
+23.93%
year
Myomo key metrics
Market Cap | 195.48M |
Enterprise value | 491.22K |
P/E | -0.51 |
EV/Sales | 0.03 |
EV/EBITDA | -0.04 |
Price/Sales | 0.33 |
Price/Book | 0.83 |
PEG ratio | -0.02 |
EPS | -0.26 |
Revenue | 19.54M |
EBITDA | -9.12M |
Income | -9.33M |
Revenue Q/Q | 8.92% |
Revenue Y/Y | 29.17% |
Profit margin | -68.92% |
Oper. margin | -68.61% |
Gross margin | 65.92% |
EBIT margin | -68.61% |
EBITDA margin | -46.66% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMyomo stock price history
Myomo stock forecast
Myomo financial statements
| Jun 2023 | 5.95M | -1.01M | -17.02% |
|---|---|---|---|
| Sep 2023 | 5.07M | -2.02M | -39.95% |
| Dec 2023 | 4.75M | -2.46M | -51.72% |
| Mar 2024 | 3.75M | -3.83M | -102.16% |
| Mar 2024 | 3.75M | -3.83M | -102.16% |
|---|---|---|---|
| Sep 2025 | 8.1M | -703.64K | -8.69% |
| Oct 2025 | 9.8M | 735.05K | 7.5% |
| Dec 2025 | 9.9M | 551.28K | 5.57% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 13296992 | 4.47M | 33.67% |
|---|---|---|---|
| Sep 2023 | 17053965 | 6.03M | 35.36% |
| Dec 2023 | 14581568 | 5.59M | 38.35% |
| Mar 2024 | 16520857 | 5.62M | 34.02% |
| Jun 2023 | -285.52K | -2.96M | -8.14K |
|---|---|---|---|
| Sep 2023 | -1.71M | -1.31M | 3.94M |
| Dec 2023 | -2.35M | 2.29M | 31 |
| Mar 2024 | -3.24M | -3.54M | 5.36M |
Myomo alternative data
| Aug 2023 | 100 |
|---|---|
| Sep 2023 | 100 |
| Oct 2023 | 100 |
| Nov 2023 | 100 |
| Dec 2023 | 100 |
| Jan 2024 | 100 |
| Feb 2024 | 100 |
| Mar 2024 | 101 |
| Apr 2024 | 101 |
| May 2024 | 101 |
| Jun 2024 | 101 |
| Jul 2024 | 101 |
Myomo other data
32.13%
+25.28%
of MYO is owned by hedge funds
2.26M
+1.78M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Aug 2023 | 177899 | 0 |
| Sep 2023 | 15000 | 0 |
| Nov 2023 | 0 | 14997 |
| Dec 2023 | 0 | 23330 |
| Mar 2024 | 50000 | 0 |
| May 2024 | 0 | 35426 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | KOVELMAN HARRY officer: Chief Medical Officer | Common Stock | 35,426 | $3.69 | $130,828 | ||
Purchase | KIRK THOMAS F director | Common Stock | 50,000 | $3.5 | $175,000 | ||
Sale | CROWLEY THOMAS ALOYSIUS JR. director | Common Stock | 14,997 | $4.08 | $61,188 | ||
Sale | KOVELMAN HARRY officer: Chief Medical Officer | Common Stock | 8,333 | $3.12 | $26,016 | ||
Sale | CROWLEY THOMAS ALOYSIUS JR. director | Common Stock | 14,997 | $3.27 | $49,040 | ||
Purchase | MORRIS MILTON MAYO director | Common Stock | 15,000 | $1.06 | $15,870 | ||
Purchase | GUDONIS PAUL R director, officer.. | Common Stock | 48,400 | $0.75 | $36,058 | ||
Purchase | KOVELMAN HARRY officer: Chief Medical Officer | Common Stock | 8,333 | $0.6 | $5,000 | ||
Purchase | HENRY DAVID A officer: Chief Financial Officer | Common Stock | 41,666 | $0.6 | $25,000 | ||
Purchase | GUDONIS PAUL R director, officer.. | Common Stock | 37,000 | $0.78 | $28,786 |
| Patent |
|---|
Application Filling date: 25 Jan 2021 Issue date: 30 Sep 2021 |
Application Filling date: 6 Aug 2020 Issue date: 19 Nov 2020 |
Application Filling date: 6 Mar 2019 Issue date: 12 Sep 2019 |
| Quarter | Transcript |
|---|---|
| Q1 2024 8 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 7 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 9 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. Paul R. Gudonis (1955) Chairman, Pres & Chief Executive Officer | $439,710 |
| Mr. David A. Henry (1961) Chief Financial Officer | $375,350 |
| Mr. Micah J. Mitchell (1976) Chief Commercial Officer | $320,610 |
-
What's the price of Myomo stock today?
One share of Myomo stock can currently be purchased for approximately $1.15.
-
When is Myomo's next earnings date?
Unfortunately, Myomo's (MYO) next earnings date is currently unknown.
-
Does Myomo pay dividends?
No, Myomo does not pay dividends.
-
How much money does Myomo make?
Myomo has a market capitalization of 195.48M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 23.7% to 19.24M US dollars.
-
What is Myomo's stock symbol?
Myomo, Inc. is traded on the AMEX under the ticker symbol "MYO".
-
What is Myomo's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Myomo?
Shares of Myomo can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Myomo's key executives?
Myomo's management team includes the following people:
- Mr. Paul R. Gudonis Chairman, Pres & Chief Executive Officer(age: 70, pay: $439,710)
- Mr. David A. Henry Chief Financial Officer(age: 64, pay: $375,350)
- Mr. Micah J. Mitchell Chief Commercial Officer(age: 49, pay: $320,610)
-
How many employees does Myomo have?
As Jul 2024, Myomo employs 101 workers.
-
When Myomo went public?
Myomo, Inc. is publicly traded company for more then 8 years since IPO on 12 Jun 2017.
-
What is Myomo's official website?
The official website for Myomo is myomo.com.
-
Where are Myomo's headquarters?
Myomo is headquartered at 137 Portland Street, Boston, MA.
-
How can i contact Myomo?
Myomo's mailing address is 137 Portland Street, Boston, MA and company can be reached via phone at +61 79969058.
Myomo company profile:
Myomo, Inc.
myomo.comExchange:
AMEX
Full time employees:
101
Industry:
Medical - Devices
Sector:
Healthcare
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
137 Portland Street
Boston, MA 02114
Boston, MA 02114
CIK: 0001369290
ISIN: US62857J2015
CUSIP: 62857J201
